J R Farndon

2.8k total citations
58 papers, 2.2k citations indexed

About

J R Farndon is a scholar working on Surgery, Genetics and Nephrology. According to data from OpenAlex, J R Farndon has authored 58 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 19 papers in Genetics and 16 papers in Nephrology. Recurrent topics in J R Farndon's work include Parathyroid Disorders and Treatments (16 papers), Neuroendocrine Tumor Research Advances (8 papers) and Pancreatic function and diabetes (8 papers). J R Farndon is often cited by papers focused on Parathyroid Disorders and Treatments (16 papers), Neuroendocrine Tumor Research Advances (8 papers) and Pancreatic function and diabetes (8 papers). J R Farndon collaborates with scholars based in United Kingdom, Sweden and Spain. J R Farndon's co-authors include Adrian L. Harris, J R C Sainsbury, Gajanan V. Sherbet, Jane Blazeby, Derek Alderson, S Nicholson, William G. Dilley, Samuel A. Wells, Timothy S. Harrison and Stephen B. Baylin and has published in prestigious journals such as The Lancet, Annals of Surgery and Gut.

In The Last Decade

J R Farndon

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J R Farndon United Kingdom 24 790 707 481 474 459 58 2.2k
N W Thompson United States 30 563 0.7× 1.2k 1.8× 828 1.7× 199 0.4× 250 0.5× 72 2.4k
Sonia L. Sugg United States 29 863 1.1× 607 0.9× 816 1.7× 833 1.8× 285 0.6× 88 2.7k
Kikuo Nutahara Japan 27 321 0.4× 530 0.7× 221 0.5× 588 1.2× 918 2.0× 107 2.1k
Takatoshi Michigishi Japan 27 509 0.6× 760 1.1× 1.1k 2.2× 261 0.6× 283 0.6× 141 2.2k
Diana Learoyd Australia 30 620 0.8× 812 1.1× 1.9k 3.9× 682 1.4× 156 0.3× 77 2.7k
Katsutaro Shimaoka United States 24 492 0.6× 522 0.7× 1.3k 2.7× 196 0.4× 288 0.6× 86 2.3k
Marie‐Elisabeth Toubert France 24 261 0.3× 637 0.9× 1.2k 2.5× 215 0.5× 265 0.6× 63 2.3k
Liborio Torregrossa Italy 30 762 1.0× 810 1.1× 2.2k 4.6× 765 1.6× 281 0.6× 119 3.3k
David Nathanson United States 24 901 1.1× 369 0.5× 509 1.1× 608 1.3× 213 0.5× 76 2.1k
Kepal N. Patel United States 22 427 0.5× 771 1.1× 1.2k 2.5× 322 0.7× 179 0.4× 70 1.9k

Countries citing papers authored by J R Farndon

Since Specialization
Citations

This map shows the geographic impact of J R Farndon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J R Farndon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J R Farndon more than expected).

Fields of papers citing papers by J R Farndon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J R Farndon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J R Farndon. The network helps show where J R Farndon may publish in the future.

Co-authorship network of co-authors of J R Farndon

This figure shows the co-authorship network connecting the top 25 collaborators of J R Farndon. A scholar is included among the top collaborators of J R Farndon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J R Farndon. J R Farndon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perks, Claire M., et al.. (2000). Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. International Journal of Cancer. 88(3). 448–453. 57 indexed citations
2.
Mihai, Radu & J R Farndon. (2000). Parathyroid disease and calcium metabolism. British Journal of Anaesthesia. 85(1). 29–43. 48 indexed citations
3.
Blazeby, Jane, Derek Alderson, & J R Farndon. (2000). Quality of Life in Patients with Oesophageal Cancer. Recent results in cancer research. 155. 193–204. 23 indexed citations
4.
Mihai, Radu, et al.. (1999). Thimerosal increases the responsiveness of the calcium receptor in human parathyroid and rMTC6–23 cells. Cell Calcium. 26(3-4). 95–101. 9 indexed citations
5.
Kabala, J., et al.. (1997). Role of preoperative localization in the management of primary hyperparathyroidism. British journal of surgery. 84(10). 1377–1380. 8 indexed citations
6.
Blazeby, Jane, Derek Alderson, Richard Steyn, et al.. (1996). Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. European Journal of Cancer. 32(11). 1912–1917. 156 indexed citations
7.
Wong, Newton A C S, et al.. (1996). Early postoperative plasma calcium concentration as a predictor of the need for calcium supplement after parathyroidectomy. British journal of surgery. 83(4). 532–534. 11 indexed citations
8.
Blazeby, Jane, et al.. (1995). Quality of life measurement in patients with oesophageal cancer.. Gut. 37(4). 505–508. 120 indexed citations
9.
Lucarotti, M E, John A. Hamilton, & J R Farndon. (1994). Somatostatin and primary hyperparathyroidism. British journal of surgery. 81(8). 1141–1143. 11 indexed citations
10.
Goddard, P R, et al.. (1992). Fat-suppression magnetic resonance imaging in the preoperative localization of parathyroid adenomas. Clinical Radiology. 46(5). 324–328. 14 indexed citations
11.
Owen, J. P., et al.. (1990). Parathyroidectomy in Chronic Renal Failure: a Nine-year Follow-up Study. QJM. 77(2). 1175–1193. 46 indexed citations
12.
Nicholson, S, et al.. (1988). Measurement of oestrogen receptor mRNA levels in human breast tumours. British Journal of Cancer. 58(5). 600–605. 44 indexed citations
13.
Wilkinson, Robert W., et al.. (1986). Intact Parathyroid Hormone Assay Offers Increased Sensitivity over C-Terminal Assays in the Study of Parathyroid Graft Function. ˜The œNephron journals/Nephron journals. 44(1). 8–10. 5 indexed citations
14.
Sainsbury, J R C, J R Farndon, Adrian L. Harris, & Gajanan V. Sherbet. (1985). Epidermal growth factor receptors on human breast cancers. British journal of surgery. 72(3). 186–188. 74 indexed citations
15.
Ellis, H. A., J. P. Owen, Michael Cassidy, et al.. (1985). Parathyroidectomy in Chronic Renal Failure. QJM. 15 indexed citations
16.
Cassidy, Michael, J. P. Owen, Henry A. Ellis, et al.. (1985). Ectopic calcification. The role of parathyroid hormone.. PubMed. 21. 888–94. 9 indexed citations
17.
Donnelly, P. K., et al.. (1984). Donor ureteric calculus presenting as acute rejection in a renal transplant recipient.. BMJ. 288(6435). 1961–1962. 4 indexed citations
18.
Lennard, T.W.J. & J R Farndon. (1983). Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis.. BMJ. 287(6385). 96–96. 7 indexed citations
19.
McLachlan, Sandra M., Anne M. Dickinson, J R Farndon, et al.. (1983). Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen.. PubMed. 52(1). 45–53. 65 indexed citations
20.
Modlin, I M, J R Farndon, Annemarie F. Shepherd, et al.. (1979). Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results. British journal of surgery. 66(7). 456–465. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026